Predicting miRNA-disease associations based on graph random propagation network and attention network

Brief Bioinform. 2022 Mar 10;23(2):bbab589. doi: 10.1093/bib/bbab589.

Abstract

Numerous experiments have demonstrated that abnormal expression of microRNAs (miRNAs) in organisms is often accompanied by the emergence of specific diseases. The research of miRNAs can promote the prevention and drug research of specific diseases. However, there are still many undiscovered links between miRNAs and diseases, which greatly limits the research of miRNAs. Therefore, for exploring the unknown miRNA-disease associations, we combine the graph random propagation network based on DropFeature with attention network to propose a novel deep learning model to predict the miRNA-disease associations (GRPAMDA). Specifically, we firstly construct the miRNA-disease heterogeneous graph based on miRNA-disease association information. Secondly, we adopt DropFeature to randomly delete the features of nodes in the graph and then perform propagation operations to enhance the features of miRNA and disease nodes. Thirdly, we employ the attention mechanism to fuse the features of random propagation by aggregating the enhanced neighbor features of miRNA and disease nodes. Finally, miRNA-disease association scores are generated by a fully connected layer. The average area under the curve of GRPAMDA model based on 5-fold cross-validation is 93.46% on HMDD v2.0. Case studies of esophageal tumors, lymphomas and prostate tumors show that 48, 47 and 46 of the top 50 miRNAs associated with these diseases are confirmed by dbDEMC and miR2Disease database, respectively. In short, the GRPAMDA model can be used as a valuable method to study miRNA-disease associations.

Keywords: DropFeature; attention mechanism; miRNA–disease association prediction; random propagation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Algorithms
  • Computational Biology / methods
  • Gene Regulatory Networks
  • Genetic Predisposition to Disease
  • Humans
  • Male
  • MicroRNAs* / genetics
  • MicroRNAs* / metabolism
  • Prostatic Neoplasms* / genetics

Substances

  • MicroRNAs